Skip to content

BACCOLO KINESITHERAPIE

Active Private limited companyfounded 2014active for 12 yearsRue Oscar Buchet (F-E) 29, 6140 Fontaine-l'EvêqueKBO/BCE: BE 0548.979.913

Lifetime

12 annual accounts with figures on one time axis
Gross marginpeak €13,274 (2017)
€786▼ 82.3%
Resultlowest -€10,156 (2018)
-€626▼ €3,545
Equitypeak €22,198 (2017)
€6,819▼ 8.4%
Debts
€7,475▼ 36.2%
Board2 names since 2014
1 directorBACCOLO STEPHANE
Documentsfilings and deeds
02-08-20262 days late
2025micro format
Gross margin from €4,436 to €786Loss of €626Debts from €11,724 to €7,475

Key points

from the 2025 annual accounts

Turnover

≈ €6,000 estimated

The accounts state no turnover.

Filings

12 annual accounts since 2014
AprilJune31 JulyOctober201520202025

Ten of the last ten came late. The 2018 accounts came latest: 152 days after the end of the period.

Checked score

81
Excellent
Financially stronger than 42% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.5% Very low
0%0.5%1.5%4%10%≥ 25%

About 5 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 2.7% 01-2025: 2.7%● unchanged vs 12-2024 02-2025: 2.7%● unchanged vs 01-2025 03-2025: 2.7%● unchanged vs 02-2025 04-2025: 2.9%▲ +0.2 percentage points vs 03-2025 05-2025: 2.9%● unchanged vs 04-2025 06-2025: 3.2%▲ +0.3 percentage points vs 05-2025 07-2025: 3.4%▲ +0.2 percentage points vs 06-2025 08-2025: 4.6%▲ +1.2 percentage points vs 07-2025 09-2025: 5.1%▲ +0.5 percentage points vs 08-2025 10-2025: 8.5%▲ +3.4 percentage points vs 09-2025highest value 11-2025: 2.0%▼ -6.5 percentage points vs 10-2025 12-2025: 0.8%▼ -1.2 percentage points vs 11-2025 01-2026: 0.7%▼ -0.1 percentage points vs 12-2025 02-2026: 0.7%● unchanged vs 01-2026 03-2026: 0.7%● unchanged vs 02-2026 04-2026: 0.7%● unchanged vs 03-2026 05-2026: 0.7%● unchanged vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 1.1%▲ +0.4 percentage points vs 07-2026 09-2026: 0.5%▼ -0.6 percentage points vs 08-2026lowest value 10-2026: 0.5%● unchanged vs 09-2026lowest value 11-2026: 0.5%● unchanged vs 10-2026lowest value

Financial strength
Strong

Solvency
73+9equity 47.7% of total assets
Liquidity
74+6short-term debt 52.3% · cash 70.5%
Profitability
43-45return on assets -4.4%

Score breakdown

raises risk
Last filed accounts filed 2 days late; 2 of the last 3 accounts late
No main activity registered
lowers risk
Size: total assets €14,294
Liquidity: current ratio 1.78, cash €10,074
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 43% of them on solvency, 68% on liquidity, 33% on profitability and 26% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,908 companies had the same profile as BACCOLO KINESITHERAPIE has now. Each dot stands for 18 companies, two years later.

90.9%
were still trading
7.8%
stopped another way
1.1%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of BACCOLO KINESITHERAPIE itself: 0.5% within 12 months.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,908 companies, not a prediction for BACCOLO KINESITHERAPIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €500 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.78 (1.49 in 2024), above the usual 1.5. Short-term debt is 52.3% and cash 70.5% of total assets. However, 52.3% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 2 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €14,294
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · No main activity registered
KBO
lowers risk · Liquidity: current ratio 1.78, cash €10,074
NBB · annual accounts
raises risk · 2025 accounts filed 2 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-08-2026, 2 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
2 days late
2024
61 days late
2023
56 days late
2022
61 days late
2021
118 days late
2020
61 days late
2019
35 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 56 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 September (4 of the last 5 accounts filed within 57 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

BS
BACCOLO STEPHANE
Director, since 27-03-2014
Board & ownership

Recent changes

Change of role: BACCOLO Stefano, from manager to director “La société a pour objet la pratique de la kinésithérapie tant en son siège qu'au domicile des patients ou au…” (deed in French) · Registered office clause: rue Oscar Buchet 29, 6140 Fontaine-l'Evêque · Gazette deed
Incorporation published on 01-04-2014 · Gazette deed
First establishment Rue Mahy Faux 181, Binche
All 20 events

Official details

Source: KBO
Status
Active since 27-03-2014Normal situation
Activity
“La société a pour objet la pratique de la kinésithérapie tant en son siège…” (deed in French)From the articles, 11 activitiesNo NACE code in the KBO yet
Establishment unit
2.229.264.0947133 Binche, since 27-03-2014
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

Total assets
€14,294▼ 25.4%
Filing
Filed on 02-08-2026
Financials

Insights on BACCOLO KINESITHERAPIE

BACCOLO KINESITHERAPIE files the micro format. That format states no turnover. The gross margin fell from €10,982 in 2014 to €786 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BACCOLO KINESITHERAPIE

What is the company number of BACCOLO KINESITHERAPIE?
The company number of BACCOLO KINESITHERAPIE is 0548.979.913. The VAT number is the same number with BE in front: BE 0548.979.913.
Where is BACCOLO KINESITHERAPIE based?
The registered office is at Rue Oscar Buchet (F-E) 29, 6140 Fontaine-l'Evêque.Company details
What is the legal form of BACCOLO KINESITHERAPIE?
BACCOLO KINESITHERAPIE is a private limited company (BV).
When was BACCOLO KINESITHERAPIE founded?
BACCOLO KINESITHERAPIE was founded on 27-03-2014.
Is BACCOLO KINESITHERAPIE still active?
Yes, BACCOLO KINESITHERAPIE is an active enterprise in the KBO register.
What is the turnover of BACCOLO KINESITHERAPIE?
The turnover in financial year 2025 is ≈ €6,000. This figure is estimated from the gross margin of €786 and 6,313 comparable companies of the same size. It probably lies between €2,700 and €14,000. It is a rough estimate.Financials
Is BACCOLO KINESITHERAPIE profitable?
In financial year 2025, BACCOLO KINESITHERAPIE made a loss of €626.
Where can I find the annual accounts of BACCOLO KINESITHERAPIE?
BACCOLO KINESITHERAPIE filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BACCOLO KINESITHERAPIE due?
BACCOLO KINESITHERAPIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.